AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gravisafe 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Best Biotech

Salt Composition

Letrozole (2.5mg)

Overview Gravisafe 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Gravisafe 2.5mg Tablets. This medication can be a standalone treatment or used alongside surgery or radiation therapy. In advanced breast cancer, it helps prevent metastasis. Gravisafe 2.5mg Tablets can be administered with or without food, always following the physician's prescribed dosage and duration for optimal results. Dosage frequency is tailored to the individual's condition and determined by their doctor to manage symptoms effectively. Continuous use is vital as directed. Common side effects include increased perspiration, fatigue, hot flushes, and elevated cholesterol (hypercholesterolemia). Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you are currently using, as these factors could influence Gravisafe's efficacy or mechanism of action. Disclose your pregnancy or breastfeeding status to your physician. Blood tests to assess vitamin D levels and bone density may be conducted before and throughout the treatment period.

Uses of Gravisafe 2.5mg Tablet

Managing Breast Cancer

Major Benefits of Gravisafe 2.5mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gravisafe 2.5mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.

Common Side effects of Gravisafe 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Gravisafe 2.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2.5mg Gravisafe tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, however, consistent timing is recommended.

How Gravisafe 2.5mg Tablet works:

Gravisafe 2.5mg tablets are classified as aromatase inhibitors. Their mechanism involves reducing the body's estrogen production—a key female hormone. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Ingestion of alcohol alongside Gravisafe 2.5mg tablets presents no known adverse reactions.

PregnancyPregnancyUNSAFE

The use of Gravisafe 2.5mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in both animal and human subjects indicates considerable risk of harm to the fetus.

Breast feedingBreast feedingUNSAFE

Lactation and Gravisafe 2.5mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Gravisafe 2.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely take Gravisafe 2.5mg tablets without a dosage change. Data on Gravisafe 2.5mg tablet use in patients with end-stage kidney disease is limited. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Gravisafe 2.5mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Gravisafe 2.5mg Tablet :

Should you forget a Gravisafe 2.5mg Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Gravisafe 2.5mg Tablet

LabelValue
Chemical Type Diphenylmethane-based compound
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Gravisafe 2.5mg Tablet

Gravisafe 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Gravisafe 2.5mg tablets are anti-estrogens. They work by inhibiting aromatase, the enzyme that produces estrogen, thereby lowering estrogen levels. This is beneficial because estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Lowering estrogen levels can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue Gravisafe 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Gravisafe 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential treatment of two years of Gravisafe 2.5mg Tablet followed by three years of tamoxifen may be used.
While irbesartan and Gravisafe 2.5mg Tablet can be taken together, monitor your blood pressure closely as Gravisafe 2.5mg Tablet may elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Gravisafe 2.5mg tablets may cause cataracts. Report blurred vision or eye irritation to your doctor promptly.
Experiencing hot flushes may indicate a common side effect of Gravisafe 2.5mg Tablets, related to decreased estrogen. These typically lessen as your body adapts, though some may persist throughout treatment and subside afterward. Consult your doctor if hot flushes are significantly troublesome.
While rare, Gravisafe 2.5mg Tablet may cause serious side effects in some individuals. These include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Gravisafe 2.5mg tablets can weaken bones (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment to detect osteoporosis.
The Ministry of Health and Family Welfare restricts Gravisafe 2.5mg Tablets to ovulation induction for anovulatory infertility.
Gravisafe 2.5mg Tablet
205